Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients

• Published in: Blood Vol. 127; no. 3; pp. 360 - 362
• Main Authors: Libura, Marta, Giebel, Sebastian, Piatkowska-Jakubas, Beata, Pawelczyk, Marta, Florek, Izabella, Matiakowska, Karolina, Jazwiec, Bozena, Borg, Katarzyna, Solarska, Iwona, Zawada, Magdalena, Czekalska, Sylwia, Libura, Jolanta, Jakobczyk, Malgorzata, Karabin, Karolina, Paluszewska, Monika, Calbecka, Malgorzata, Gajkowska-Kulik, Justyna, Gadomska, Grazyna, Kielbinski, Marek, Ejduk, Anna, Kata, Dariusz, Grosicki, Sebastian, Wierzbowska, Agnieszka, Kyrcz-Krzemien, Slawomira, Warzocha, Krzysztof, Kuliczkowski, Kazimierz, Skotnicki, Aleksander, Holowiecki, Jerzy, Jedrzejczak, Wieslaw Wiktor, Haus, Olga
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 21.01.2016
• Subjects: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cladribine - administration & dosage; Cytarabine - administration & dosage; Daunorubicin - administration & dosage; fms-Like Tyrosine Kinase 3 - genetics; Gene Duplication; Humans; Karyotype; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - genetics; Leukemia, Myeloid, Acute - mortality; Treatment Outcome